Company overview
Lifebit provides a federated AI data platform that enables pharma and life sciences companies to analyze distributed biomedical datasets securely without moving sensitive data. Key offerings include real-time data integration, AI-driven insights, natural language query processing, and access to over 270 million consented patient records via a trusted data marketplace. The platform supports drug discovery, clinical analytics, and multi-omic data handling through patented federated technology and rapid data products.
Lifebit is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include federated ai, pharma data platform, drug discovery ai, secure data analysis, multi-omic data.
Structured facts
- Website
- https://lifebit.ai
- Markets served
- United States & Americas
- Keywords
- federated ai, pharma data platform, drug discovery ai, secure data analysis, multi-omic data
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What are Lifebit's key capabilities for pharma R&D?
- Lifebit offers federated AI for secure analysis of distributed datasets, real-time data integration, AI-driven insights, natural language query processing, and support for large-scale multi-omic and real-world data.
- How does Lifebit ensure data security and compliance?
- Lifebit uses patented federated technology to analyze data in-situ without movement, reducing interception risks, and provides governance for consented patient records in its trusted data marketplace.
- What geographies and data types does Lifebit support?
- Lifebit enables global access to distributed biomedical data, including 270M+ consented patient records across EHR, claims, and genomics, with rapid data products for instant research access.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
